Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are being investigated or treated for chest (thoracic) cancers using therapies that target specific gene mutations in the tumour
- People aged 18 years or older
- People who either (a) have signs that their cancer may be growing or have a medical condition that means their doctor has already planned a standard procedure — such as a biopsy, fluid drainage, or surgery — that would produce a tumour sample suitable for analysis, or (b) have already had a biopsy or surgery at the University of Colorado or another hospital, with tumour tissue available for analysis (confirm with trial site)
- People who are able to understand the study information and are willing to sign a consent form
Who may not be able to join:
- No exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Erin Schenk, MD, PhD, University of Colorado, Denver
Phone: 303-724-1657
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To identify baseline and treatment-related somatic changes in the tumor tissue from patients with lung and other thoracic cancers.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.